Phibro Animal Health | PAHC - 资产

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 2.37B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	资产	更改		日
Align Technology	USD 6.31B		80.48M	2026-03
ANI Pharmaceuticals	USD 1.44B		32.22M	2025-12
Assertio Holdings	USD 319.77M		46M	2025-09
Aurora Cannabis	CAD 775.29M		18.43M	2025-12
Bristol-Myers Squibb	USD 86.48B		3.56B	2026-03
Canopy Growth	CAD 1.11B		36.35M	2025-12
Corcept Therapeutics	USD 814.88M		21.77M	2026-03
Eli Lilly	USD 116.58B		4.1B	2026-03
Henry Schein	USD 11.3B		89M	2026-03
Idexx Laboratories	USD 3.39B		34.74M	2026-03
Knight Therapeutics	CAD 1.05B		2.28M	2025-12
Merck	USD 128.68B		8.18B	2026-03
Nektar Therapeutics	USD 280.41M		20.94M	2025-12
Pacira	USD 1.21B		56.38M	2026-03
Phibro Animal Health	USD 1.45B		39.56M	2026-03
Prestige Brands	USD 3.49B		52.46M	2025-12
Supernus Pharmaceuticals	USD 1.5B		48.08M	2026-03
Zoetis	USD 15.15B		313M	2026-03